Effects of Health Maintenance Organization Coverage of Self-monitoring Devices on Diabetes Self-care and Glycemic Control

Open Access
Publisher Website
Google Scholar
Abstract
Increasingly, public and private insurers, including managed care organizations (MCOs), face challenging decisions regarding coverage of self-monitoring devices for managing major chronic illnesses, such as diabetes. Guided by clinical experience but little experimental data, self-monitoring of blood glucose (SMBG) has become a key feature of secondary prevention and treatment of diabetes.1 The goal of such monitoring is to guide daily therapeutic management to achieve "tight" glycemic control and thereby reduce major complications of diabetes, including retinopathy, neuropathy, and cardiovascular and end-stage renal disease.

This publication has 19 references indexed in Scilit: